Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover)
AssigneeUniversity of Miami
InventorsStephen C. Pflugfelder, Scheffer C. G. Tseng, Andrew J. W. Huang
Life of this patent
Estimating the term…
Abstract
A preservative-free composition containing an effective amount of a corticosteroid in an aqueous carrier to treat a dry eye condition. The composition may be provided as a part of a therapeutic regimen to treat a variety of dry eye conditions and ocular surface disorders manifesting delayed tear clearance previously not readily treatable. The composition may be packaged as containers of single dosage amounts of the corticosteroid-aqueous composition sufficient for pulsed-therapy of acute exacerbations of the irritation symptoms and ocular surface disease of conditions associated with dry eye and delayed tear clearance.
Claims7
A process for treatment of an ocular disease associated with delayed tear clearance or a dry eye condition in a patient comprising the steps of
- (a) identifying a patient having an ocular disease associated with delayed tear clearance (turnover) or a dry eye condition suitable for treatment with a corticosteroid, and
- (b) topically administering to an eye of said patient a nonpreserved solution, suspension, or gel comprising an aqueous carrier and an amount of a corticosteroid sufficient to alleviate said delayed tear clearance or dry eye condition.
Dependencies are inferred from the claim text.